Linical Co., Ltd. (2183.T)
JPY 330.0
(0.92%)
JPY 330.0
(0.92%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.77 Billion JPY | -17.56% |
| 2022 | 4.16 Billion JPY | 15.23% |
| 2021 | 3.61 Billion JPY | 30.49% |
| 2020 | 2.76 Billion JPY | -21.61% |
| 2019 | 3.53 Billion JPY | -7.41% |
| 2018 | 3.81 Billion JPY | 7.92% |
| 2017 | 3.53 Billion JPY | -3.67% |
| 2016 | 3.66 Billion JPY | 6.19% |
| 2015 | 3.45 Billion JPY | 93.16% |
| 2014 | 1.78 Billion JPY | 25.87% |
| 2013 | 1.42 Billion JPY | -14.11% |
| 2012 | 1.65 Billion JPY | 22.15% |
| 2011 | 1.35 Billion JPY | 40.74% |
| 2010 | 962.04 Million JPY | -9.8% |
| 2009 | 1.06 Billion JPY | -5.07% |
| 2008 | 1.12 Billion JPY | 46.16% |
| 2007 | 768.68 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 723 Million JPY | 0.93% |
| 2023 Q1 | 947.39 Million JPY | -19.17% |
| 2023 Q3 | 898.35 Million JPY | -13.39% |
| 2023 FY | 3.43 Billion JPY | -17.56% |
| 2023 Q4 | 716.33 Million JPY | -20.26% |
| 2023 Q2 | 1.03 Billion JPY | 9.48% |
| 2022 FY | 4.16 Billion JPY | 15.23% |
| 2022 Q4 | 1.17 Billion JPY | 1.99% |
| 2022 Q3 | 1.14 Billion JPY | 3.5% |
| 2022 Q2 | 1.11 Billion JPY | 52.09% |
| 2022 Q1 | 730.09 Million JPY | -21.73% |
| 2021 Q1 | 712.57 Million JPY | -9.51% |
| 2021 Q2 | 964.15 Million JPY | 35.31% |
| 2021 Q3 | 1 Billion JPY | 3.93% |
| 2021 Q4 | 932.83 Million JPY | -6.9% |
| 2021 FY | 3.61 Billion JPY | 30.49% |
| 2020 Q2 | 888.82 Million JPY | 88.05% |
| 2020 Q3 | 618.68 Million JPY | -30.39% |
| 2020 FY | 2.76 Billion JPY | -21.61% |
| 2020 Q4 | 787.43 Million JPY | 27.28% |
| 2020 Q1 | 472.66 Million JPY | -39.25% |
| 2019 Q2 | 1.09 Billion JPY | 47.35% |
| 2019 Q1 | 741.93 Million JPY | -7.8% |
| 2019 Q3 | 917.28 Million JPY | -16.1% |
| 2019 Q4 | 778.06 Million JPY | -15.18% |
| 2019 FY | 3.53 Billion JPY | -7.41% |
| 2018 FY | 3.81 Billion JPY | 7.92% |
| 2018 Q4 | 804.68 Million JPY | -16.23% |
| 2018 Q3 | 960.62 Million JPY | -19.42% |
| 2018 Q2 | 1.19 Billion JPY | 39.33% |
| 2018 Q1 | 855.68 Million JPY | -7.19% |
| 2017 Q4 | 921.95 Million JPY | 0.02% |
| 2017 FY | 3.53 Billion JPY | -3.67% |
| 2017 Q2 | 997.44 Million JPY | 44.1% |
| 2017 Q3 | 921.74 Million JPY | -7.59% |
| 2017 Q1 | 692.17 Million JPY | -20.7% |
| 2016 FY | 3.66 Billion JPY | 6.19% |
| 2016 Q3 | 925.13 Million JPY | -17.79% |
| 2016 Q2 | 1.12 Billion JPY | 51.11% |
| 2016 Q4 | 872.88 Million JPY | -5.65% |
| 2016 Q1 | 744.67 Million JPY | -10.59% |
| 2015 FY | 3.45 Billion JPY | 93.16% |
| 2015 Q4 | 832.91 Million JPY | 1.31% |
| 2015 Q3 | 822.11 Million JPY | -29.55% |
| 2015 Q2 | 1.16 Billion JPY | 84.6% |
| 2015 Q1 | 632.13 Million JPY | -8.75% |
| 2014 FY | 1.78 Billion JPY | 25.87% |
| 2014 Q4 | 692.76 Million JPY | 71.02% |
| 2014 Q3 | 405.07 Million JPY | 4.27% |
| 2014 Q2 | 388.5 Million JPY | 28.72% |
| 2014 Q1 | 301.82 Million JPY | -26.52% |
| 2013 Q1 | 266.12 Million JPY | -45.52% |
| 2013 FY | 1.42 Billion JPY | -14.11% |
| 2013 Q3 | 346.03 Million JPY | -13.0% |
| 2013 Q4 | 410.75 Million JPY | 18.71% |
| 2013 Q2 | 397.75 Million JPY | 49.46% |
| 2012 Q3 | 340.23 Million JPY | -20.81% |
| 2012 Q1 | 395.58 Million JPY | -5.65% |
| 2012 Q2 | 429.66 Million JPY | 8.62% |
| 2012 Q4 | 488.49 Million JPY | 43.58% |
| 2012 FY | 1.65 Billion JPY | 22.15% |
| 2011 FY | 1.35 Billion JPY | 40.74% |
| 2011 Q1 | 190.18 Million JPY | -15.51% |
| 2011 Q2 | 385.32 Million JPY | 102.6% |
| 2011 Q3 | 359.22 Million JPY | -6.77% |
| 2011 Q4 | 419.26 Million JPY | 16.72% |
| 2010 FY | 962.04 Million JPY | -9.8% |
| 2010 Q2 | 306.86 Million JPY | 31.35% |
| 2010 Q1 | 233.61 Million JPY | -19.44% |
| 2010 Q3 | 196.46 Million JPY | -35.98% |
| 2010 Q4 | 225.09 Million JPY | 14.57% |
| 2009 Q1 | 343.51 Million JPY | -18.15% |
| 2009 FY | 1.06 Billion JPY | -5.07% |
| 2009 Q4 | 290 Million JPY | 112.16% |
| 2009 Q3 | 136.69 Million JPY | -53.88% |
| 2009 Q2 | 296.37 Million JPY | -13.72% |
| 2008 Q4 | 419.68 Million JPY | 75.79% |
| 2008 Q2 | 266.96 Million JPY | 0.0% |
| 2008 FY | 1.12 Billion JPY | 46.16% |
| 2008 Q3 | 238.74 Million JPY | -10.57% |
| 2007 FY | 768.68 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | -100.834% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -4604.863% |
| GNI Group Ltd. | 22.43 Billion JPY | 83.156% |
| Trans Genic Inc. | 2.24 Billion JPY | -67.979% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -3745.506% |
| Soiken Holdings Inc. | 2.48 Billion JPY | -52.205% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | -192.299% |
| AnGes, Inc. | -3.06 Billion JPY | 223.26% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 2226.001% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 60.903% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -630.396% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -3305.212% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | -160.464% |
| CanBas Co., Ltd. | -984 Million JPY | 483.972% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -864.592% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | -128.137% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -847.901% |
| Kidswell Bio Corporation | 1.03 Billion JPY | -263.512% |
| PeptiDream Inc. | 17.21 Billion JPY | 78.057% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -12245.326% |
| Ribomic Inc. | -10.5 Million JPY | 36076.833% |
| SanBio Company Limited | -14.5 Million JPY | 26149.966% |
| Healios K.K. | 108 Million JPY | -3398.414% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 1108102.053% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 6498.887% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 249986.706% |
| StemRIM | -44.34 Million JPY | 8619.441% |
| CellSource Co., Ltd. | 3.18 Billion JPY | -18.627% |
| FunPep Company Limited | -680.28 Million JPY | 655.396% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -5356.01% |
| Stella Pharma Corporation | 217.29 Million JPY | -1638.758% |
| TMS Co., Ltd. | -6.95 Million JPY | 54463.842% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -1101.13% |
| Cuorips Inc. | 9.63 Million JPY | -39130.475% |
| K Pharma,Inc. | 910 Million JPY | -315.196% |
| Takara Bio Inc. | 25.45 Billion JPY | 85.158% |
| ReproCELL Incorporated | 1.1 Billion JPY | -242.012% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | -216.159% |
| StemCell Institute Inc. | 1.57 Billion JPY | -139.757% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | -126.681% |
| CellSeed Inc. | 107.15 Million JPY | -3426.002% |